Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

17
Number of overlapping holdings
34.0%
% of FTXH's 51 holdings also in PJP
56.7%
% of PJP's 30 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in PJP |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 8.1% | 5.3% | 5.3% | |
MERCK & CO. INC. | 7.1% | 4.8% | 4.8% | |
ABBVIE INC | 7.0% | 4.8% | 4.8% | |
PFIZER INC | 7.1% | 4.7% | 4.7% | |
GILEAD SCIENCES INC | 3.9% | 5.3% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PJP
BRISTOL-MYERS SQUIBB CO | 4.4% | |
ZOETIS INC | 3.8% | |
JOHNSON & JOHNSON | 2.7% | |
PFIZER INC | 2.4% | |
MERCK & CO. INC. | 2.3% | |
ORGANON & CO. | 2.3% | |
ABBVIE INC | 2.2% | |
EXELIXIS INC | 2.1% | |
MEDPACE HOLDINGS, INC. | 1.9% | |
HALOZYME THERAPEUTICS INC | 1.6% |
FTXH Underweight Relative to PJP
ABBOTT LABORATORIES | -5.4% | |
BIOSANTE PHARMACEUTICALS INC | -3.9% | |
TARSUS PHARMACEUTICALS, INC. | -3.7% | |
INNOVIVA, INC. | -3.1% | |
PACIRA PHARMACEUTICALS INC | -3.0% | |
SUPERNUS PHARMACEUTICALS INC | -2.9% | |
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% | |
LIQUIDIA TECHNOLOGIES, INC. | -2.7% | |
LIGAND PHARMACEUTICALS-CL B | -2.7% | |
CORCEPT THERAPEUTICS INC | -2.5% |